文献速递肺栓塞与肺血管病

锌介导的可溶性环氧化物水解酶抑制促进肺动脉高压

Zinc-mediated Inhibition of Soluble Epoxide Hydrolase Promotes Pulmonary Hypertension.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01

本研究探讨锌介导的可溶性环氧化物水解酶(sEH)抑制在缺氧条件下促进肺动脉高压(PH)和血管重构的机制。通过活性实验、突变分析和C230A敲入小鼠模型,发现锌通过结合C232/C230和C423抑制sEH,而C230A小鼠对急慢性缺氧诱导的PH具有保护作用。患者肺样本显示sEH表达降低,UK Biobank中sEH功能缺失突变与PH风险增加相关。结论:sEH活性丧失(遗传、急性锌依赖抑制或慢性锌依赖蛋白丢失)最终导致PH,靶向该通路可能提供新的治疗机会。

要点

  • 锌通过结合sEH的C232/C230和C423抑制其活性。
  • C230A敲入小鼠抵抗急慢性缺氧诱导的PH和血管重构。
  • sEH功能缺失突变与PH风险增加相关。

核心结论

  • sEH活性丧失(遗传、急性锌依赖抑制或慢性锌依赖蛋白丢失)最终导致肺动脉高压。
  • 靶向sEH通路可能提供新的肺动脉高压治疗机会。

研究设计与样本

  • 研究采用活性实验、突变分析和电感耦合质谱鉴定关键半胱氨酸。
  • 使用肺动脉和人肺动脉平滑肌细胞测量血管收缩反应。
  • 生成C230A敲入小鼠,在急性和慢性缺氧体内模型中阐明机制。
  • 评估特发性肺动脉高压或慢性阻塞性肺疾病患者的sEH表达。
  • 利用UK Biobank数据评估sEH突变与PH风险关联。

主要发现

  • 锌通过结合C232/C230和C423抑制sEH。
  • C230A小鼠抵抗急性缺氧诱导的sEH抑制、EET积累和肺动脉压升高。
  • C230A小鼠抵抗慢性缺氧诱导的PH及相关重构和sEH表达丢失。
  • 患者肺样本显示sEH表达降低。
  • UK Biobank中sEH功能缺失突变参与者发生PH风险更高。

临床怎么用

  • sEH活性丧失是肺动脉高压发展的关键机制,提示靶向sEH通路可能成为治疗策略。
  • 锌介导的sEH抑制可能作为生物标志物或治疗靶点,需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Pulmonary hypertension (PH) and vascular remodeling involve complex molecular mechanisms, with zinc and epoxyeicosatrienoic acids playing key roles. Objectives: We sought to investigate whether zinc-mediated inhibition of soluble epoxide hydrolase contributes to the development of PH and vascular remodeling under hypoxic conditions. Methods: Activity assays measured zinc-mediated soluble epoxide hydrolase inhibition, with mutagenesis and inductively coupled mass spectrometry identifying key cysteines. Pulmonary arteries and human pulmonary artery smooth muscle cells were used to measure vasoconstriction in response to epoxyeicosatrienoic acid, zinc, soluble epoxide hydrolase inhibition, or hypoxia treatment. A C230A knockin mouse was generated to elucidate the mechanism in vivo in acute and chronic hypoxia. Hydrolase expression was assessed in patients with idiopathic pulmonary artery hypertension or chronic obstructive pulmonary disease. Using UK Biobank data, soluble epoxide hydrolase mutations were assessed for a link to increased PH risk. Measurements and Main Results: Zinc inhibited soluble epoxide hydrolase by binding to C232/C230 and C423. C230A mice, resistant to zinc binding, were protected from acute hypoxia-induced soluble epoxide hydrolase inhibition, epoxyeicosatrienoic acid accumulation, and increased pulmonary pressure. C230A mice were also resistant to chronic hypoxia-induced PH and to the associated remodeling and loss of hydrolase expression. Patient lung samples showed decreased soluble epoxide hydrolase expression, echoing our findings with mice. UK Biobank participants with loss-of-function mutations in soluble epoxide hydrolase exhibited a higher risk of developing PH. Conclusions: Loss of soluble epoxide hydrolase activity, whether due to genetics, acute zinc-dependent inhibition, or chronic zinc-dependent loss of hydrolase protein, ultimately results in PH, and targeting this pathway may offer new therapeutic opportunities.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Simoes de Jesus D, Buffonge S, Abis G, et al. Zinc-mediated Inhibition of Soluble Epoxide Hydrolase Promotes Pulmonary Hypertension. Am J Respir Crit Care Med. 2025. PMID: 40504769. doi:10.1164/rccm.202409-1763OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。